News
DYNE-251 received FDA breakthrough therapy designation, showcasing its potential for patients with Duchenne muscular ...
Anaheim Ducks right wing Troy Terry is trading his hockey stick for a driver this September as he takes on a new kind of role ...
7h
TipRanks on MSNDyne Therapeutics Advances DMD Treatment with DYNE-251 Study
Dyne Therapeutics, Inc. (($DYN)) announced an update on their ongoing clinical study. Dyne Therapeutics, Inc. is conducting a study titled A ...
Jefferies analysts said these detailed safety outcomes confirm the gene therapy's positive risk/benefit profile in ambulatory ...
12h
TipRanks on MSNSatellos Bioscience Announces Positive Phase 1b Results and Upcoming Clinical Trials for DMD
Satellos Bioscience ( ($TSE:MSCL) ) has provided an announcement. Satellos Bioscience reported positive results from its Phase 1b study of ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
She was joined by her partner Lewis Mann, and the pair raised over £500 for Muscular Dystrophy UK, the leading charity for ...
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results